238 related articles for article (PubMed ID: 32553300)
1. Pathology of meningiomas.
Solomon DA; Pekmezci M
Handb Clin Neurol; 2020; 169():87-99. PubMed ID: 32553300
[TBL] [Abstract][Full Text] [Related]
2. "Rhabdoid" meningioma: an aggressive variant.
Perry A; Scheithauer BW; Stafford SL; Abell-Aleff PC; Meyer FB
Am J Surg Pathol; 1998 Dec; 22(12):1482-90. PubMed ID: 9850174
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
4. Necrotic rhabdoid meningiomas with aggressive clinical behavior.
Matyja E; Grajkowska W; Nauman P; Bonicki W; Bojarski P; Marchel A
Clin Neuropathol; 2010; 29(5):307-16. PubMed ID: 20860894
[TBL] [Abstract][Full Text] [Related]
5. Chordoid meningioma: a report of ten cases.
Tena-Suck ML; Collado-Ortìz MA; Salinas-Lara C; García-López R; Gelista N; Rembao-Bojorquez D
J Neurooncol; 2010 Aug; 99(1):41-8. PubMed ID: 20094774
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.
Bollag RJ; Vender JR; Sharma S
Neuropathology; 2010 Jun; 30(3):279-87. PubMed ID: 19780983
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative cytologic diagnosis of chordoid meningioma. A case report.
Salinero E; Beltran L; Costa JR
Acta Cytol; 2004; 48(2):259-63. PubMed ID: 15085764
[TBL] [Abstract][Full Text] [Related]
8. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.
Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W
Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
van de Nes JA; Griewank KG; Schmid KW; Grabellus F
Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
[TBL] [Abstract][Full Text] [Related]
10. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas.
Lin YW; Tai SH; Huang YH; Chang CC; Juan WS; Chao LC; Wen MJ; Hung YC; Lee EJ
Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
[TBL] [Abstract][Full Text] [Related]
12. June 2004: a male in his late 60s with recurrent extracerebral tumor.
Mawrin C; Hahne R; Scherlach C; Kirches E; Dietzmann K
Brain Pathol; 2004 Oct; 14(4):457-9. PubMed ID: 15605995
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes.
Durand A; Champier J; Jouvet A; Labrousse F; Honnorat J; Guyotat J; Fèvre-Montange M
Clin Neuropathol; 2008; 27(5):334-45. PubMed ID: 18808065
[TBL] [Abstract][Full Text] [Related]
14. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.
Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M
Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic meningioma with papillary, rhabdoid, and epithelial features: a case report.
Saito A; Nakazato Y; Yoshii Y; Hyodo A; Harakuni T; Toita T; Ogawa K; Horikawa K; Terada Y; Kinjo S; Minei S
Brain Tumor Pathol; 2001; 18(2):155-9. PubMed ID: 11908873
[TBL] [Abstract][Full Text] [Related]
18. Clear cell meningioma with frequent chordoid features and aggressive behavior: a clinicopathologic study of ten cases at a single institution.
Chen HK; Wu YT; Lin YJ; Lin JW
J Neurooncol; 2011 Jul; 103(3):551-9. PubMed ID: 20872042
[TBL] [Abstract][Full Text] [Related]
19. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
[TBL] [Abstract][Full Text] [Related]
20. Expression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma.
Liu Y; Sturgis CD; Bunker M; Saad RS; Tung M; Raab SS; Silverman JF
Mod Pathol; 2004 Sep; 17(9):1129-33. PubMed ID: 15133478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
